Related references
Note: Only part of the references are listed.Primary peritoneal epithelioid mesothelioma of clear cell type with a novel VHL gene mutation: a case report
Alexandria Smith-Hannah et al.
HUMAN PATHOLOGY (2019)
Immunotherapy strategies for mesothelioma - the role of tumor specific neoantigens in a new era of precision medicine
Linda Ye et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2019)
Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival
Vivek Verma et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group
Aliya Noor Husain et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Immunohistochemistry in Peritoneal Mesothelioma A Single-Center Experience of 244 Cases
Radhika Theresa Tandon et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
Theo A. Knijnenburg et al.
CELL REPORTS (2018)
Malignant peritoneal mesothelioma, clear cell variant, in a female and its differentiation from clear cell carcinoma
Hiroko Hayashi et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
Personalized T cell-mediated cancer immunotherapy: progress and challenges
Michael T. Bethune et al.
CURRENT OPINION IN BIOTECHNOLOGY (2017)
New Markers for Separating Benign From Malignant Mesothelial Proliferations Are We There Yet?
Andrew Churg et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray
Marcello Deraco et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis
Deepa Magge et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Peritoneal Malignant Mesothelioma Metastatic to Supraclavicular Lymph Nodes
Stefano Zannella et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2014)
Identification of actionable mutations in malignant pleural mesothelioma
Takehito Shukuya et al.
LUNG CANCER (2014)
MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma
Edmund A. Mroz et al.
ORAL ONCOLOGY (2013)
Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma
H. Richard Alexander et al.
SURGERY (2013)
Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005
Suresh H. Moolgavkar et al.
CANCER CAUSES & CONTROL (2009)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Clear cell mesothelioma presenting as an incarcerated abdominal hernia
NG Ordóñez
VIRCHOWS ARCHIV (2005)
Medical progress - Advances in malignant mesothelioma
BWS Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mesothelioma with clear cell features:: an ultrastructural and immunohistochemical study of 20 cases
NG Ordóñez
HUMAN PATHOLOGY (2005)
Share Paper
